BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28851896)

  • 1. Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients.
    Zhang S; Wang C; Huang H; Jiang Q; Zhao D; Tian Y; Ma J; Yuan W; Sun Y; Che X; Zhang J; Chen H; Zhao Y; Chu Y; Zhang Y; Chen Y
    Sci Rep; 2017 Aug; 7(1):9572. PubMed ID: 28851896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis.
    Ma Y; Che NY; Liu YH; Shu W; Du J; Xie SH; Li L
    Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):651-657. PubMed ID: 30771122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.
    Li SS; Zhou CY; Liao R; Xiong L; Weng NN; Zhao YQ; Mason C; Gou HF; Yi C; Zhu Q
    Medicine (Baltimore); 2020 Apr; 99(14):e19413. PubMed ID: 32243360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck.
    Fortin A; Wang CS; Vigneault E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1062-9. PubMed ID: 19036528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
    Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
    Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.
    Chaiteerakij R; Petersen GM; Bamlet WR; Chaffee KG; Zhen DB; Burch PA; Leof ER; Roberts LR; Oberg AL
    J Clin Oncol; 2016 Jun; 34(16):1898-904. PubMed ID: 27069086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
    Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
    Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma.
    Talamini R; Polesel J; Spina M; Chimienti E; Serraino D; Zucchetto A; Zanet E; Franceschi S; Tirelli U
    Int J Cancer; 2008 Apr; 122(7):1624-9. PubMed ID: 18059029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of second primary pancreatic cancer.
    Jo JH; Cho IR; Jung JH; Lee HS; Chung MJ; Bang S; Park SW; Chung JB; Song SY; Park JY
    PLoS One; 2017; 12(6):e0179784. PubMed ID: 28650984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint and independent effect of alcohol and tobacco use on the risk of subsequent cancer incidence among cancer survivors: A cohort study using cancer registries.
    Tabuchi T; Ozaki K; Ioka A; Miyashiro I
    Int J Cancer; 2015 Nov; 137(9):2114-23. PubMed ID: 25904109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco smoking, alcohol consumption and pancreatic cancer risk: a case-control study in Italy.
    Talamini R; Polesel J; Gallus S; Dal Maso L; Zucchetto A; Negri E; Bosetti C; Lucenteforte E; Boz G; Franceschi S; Serraino D; La Vecchia C
    Eur J Cancer; 2010 Jan; 46(2):370-6. PubMed ID: 19782561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol drinking as an unfavorable prognostic factor for male patients with nasopharyngeal carcinoma.
    Chen YP; Zhao BC; Chen C; Lei XX; Shen LJ; Chen G; Yan F; Wang GN; Chen H; Jiang YQ; Xia YF
    Sci Rep; 2016 Jan; 6():19290. PubMed ID: 26776301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and alcohol drinking effect on radiotherapy associated risk of second primary cancer and mortality among breast cancer patients.
    DiMarzio P; Peila R; Dowling O; Timony DM; Balgobind A; Lee LN; Kostroff KM; Ho GYF
    Cancer Epidemiol; 2018 Dec; 57():97-103. PubMed ID: 30359894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
    Lembeck AL; Posch F; Klocker EV; Szkandera J; Schlick K; Stojakovic T; Kornprat P; Lackner C; Gerger A; Stoeger H; Stotz M; Pichler M
    Clin Chem Lab Med; 2019 Apr; 57(5):740-744. PubMed ID: 30307891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer patients who smoke and drink are diagnosed at younger ages.
    Brand RE; Greer JB; Zolotarevsky E; Brand R; Du H; Simeone D; Zisman A; Gorchow A; Lee SY; Roy HK; Anderson MA
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):1007-12. PubMed ID: 19560558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
    Hashibe M; Brennan P; Benhamou S; Castellsague X; Chen C; Curado MP; Dal Maso L; Daudt AW; Fabianova E; Fernandez L; Wünsch-Filho V; Franceschi S; Hayes RB; Herrero R; Koifman S; La Vecchia C; Lazarus P; Levi F; Mates D; Matos E; Menezes A; Muscat J; Eluf-Neto J; Olshan AF; Rudnai P; Schwartz SM; Smith E; Sturgis EM; Szeszenia-Dabrowska N; Talamini R; Wei Q; Winn DM; Zaridze D; Zatonski W; Zhang ZF; Berthiller J; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):777-89. PubMed ID: 17505073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
    Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
    BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.